# A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer

> **NCT01000480** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 90 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Pemetrexed
- **DRUG:** Cisplatin
- **RADIATION:** Thoracic Radiotherapy

## Key facts

- **NCT ID:** NCT01000480
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2013-01
- **Final completion:** 2013-07
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2014-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01000480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01000480, "A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01000480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*